Literature DB >> 4074609

Cortisol does not inhibit prednisolone clearance.

P J Meffin, B C Sallustio, Y J Purdie, R A Robson, L M Wing, P M Brooks.   

Abstract

The disposition of prednisolone has been studied in eight male subjects with and without the concomitant administration of cortisol which produced plasma cortisol concentrations 10-fold higher than endogenous levels. The clearance and steady-state distribution volume of total prednisolone were increased as was the prednisolone free fraction but the clearance of unbound prednisolone was unaltered by cortisol co-administration.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4074609      PMCID: PMC1400879          DOI: 10.1111/j.1365-2125.1985.tb05087.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  5 in total

1.  Alterations in prednisolone disposition as a result of oral contraceptive use and dose.

Authors:  P J Meffin; L M Wing; B C Sallustio; P M Brooks
Journal:  Br J Clin Pharmacol       Date:  1984-06       Impact factor: 4.335

2.  Diurnal variation in prednisolone kinetics.

Authors:  J English; M Dunne; V Marks
Journal:  Clin Pharmacol Ther       Date:  1983-03       Impact factor: 6.875

3.  Alterations in prednisolone disposition as a result of time of administration, gender and dose.

Authors:  P J Meffin; P M Brooks; B C Sallustio
Journal:  Br J Clin Pharmacol       Date:  1984-04       Impact factor: 4.335

4.  Iron-EDTA stimulated reduction of indicine N-oxide by the hepatic microsomal fraction, isolated hepatocytes, and the intact rat.

Authors:  G Powis; B A Svingen; C Degraw
Journal:  Biochem Pharmacol       Date:  1982-02-01       Impact factor: 5.858

5.  Prednisolone disposition and protein binding in oral contraceptive users.

Authors:  S J Boekenoogen; S J Szefler; W J Jusko
Journal:  J Clin Endocrinol Metab       Date:  1983-04       Impact factor: 5.958

  5 in total
  1 in total

Review 1.  Clinical pharmacokinetics of prednisone and prednisolone.

Authors:  B M Frey; F J Frey
Journal:  Clin Pharmacokinet       Date:  1990-08       Impact factor: 6.447

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.